Targeting regulation of the tumour microenvironment induces apoptosis of breast cancer cells by an affinity hemoperfusion adsorbent
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 49 (1) , 325-334
Abstract
The cytokine network of tumour microenvironment (TME) plays an important role in cancer growth and progression. The current work aims to provide a new strategy for cancer therapy based on the targeted regulation of cytokines in the TME. Here, heparin-coupled polyvinyl alcohol (PVA-H) microspheres have been developed as an adsorbent for selectively remove tumour-induced immunosuppressive cytokines, such as vascular endothelial growth factor (VEGF) and transforming growth factor-beta (TGF-β), but not tumour necrosis factor-alpha (TNF-α) which has an immune-stimulating effect and can inhibit tumour growth. The proliferation and apoptosis of breast cancer cells after perfusion were tested by cell viability assays, flow cytometry analysis and mRNA microarray assays. Results showed that the PVA-H microspheres efficiently absorbed the majority of VEGF (74.39%) and TGF-β (86.39%), but much less TNF-α (4.16%). The regulation of the cytokines had remarkable anti-proliferative and pro-apoptotic effects on breast cancer cells, which was further confirmed from the change of mRNA expression levels. Thus, targeting regulatory pathways within the TME by an affinity adsorbent that selectively depletes immunosuppressive cytokines is potentially a new and promising strategy for cancer therapy.Keywords
Funding Information
- National Key R&D Program of China (2017YFC1104401)
- National Natural Science Foundation of China (81771986)
- Natural Science Foundation of Tianjin (18YFZCSY00860)
- Tianjin Science and Technology Project (16ZXMJSY00170)
This publication has 38 references indexed in Scilit:
- Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 studyThe Lancet Oncology, 2020
- Tumour exosome integrins determine organotropic metastasisNature, 2015
- Amphiphilic polyvinyl alcohol adsorbent for the removal of low-density lipoproteinArtificial Cells, Nanomedicine, and Biotechnology, 2014
- Macroporous poly(vinyl alcohol) microspheres bearing phosphate groups as a new adsorbent for low-density lipoprotein apheresisBiomedical Materials, 2009
- Cytokine regulation networks in the cancer microenvironmentFrontiers in Bioscience-Landmark, 2008
- Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitroAngiogenesis, 2005
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerNature Medicine, 2004
- Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-βBreast Cancer Research, 2000
- VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast CancerThe American Journal of Pathology, 1999